AUSTIN, Texas, Nov. 13, 2012 /PRNewswire/ -- dailyRx, Inc., a leading digital news publisher, announced today the top five health conditions and medications viewed on the dailyRx News Network during October 2012. dailyRx News is syndicated to consumers across the digital landscape and throughout its national health provider network via websites, social media channels, and mobile applications.

"dailyRx News is focused on offering patients and consumers on-demand access to trusted, easy-to-understand health news and information in their preferred media format," said Donald W. Hackett, CEO and Publisher.  

"We are integrating patient education at key touch points throughout the spectrum of care delivery to engage patients in their health and empower more informed decision making," Hackett added.

• Cancer – 5.8MM Pageviews
• Arthritis – 5.4MM Pageviews
• Children's Health – 3.6MM Pageviews
• HIV/AIDS – 3.2MM Pageviews
• Allergies – 3.0MM Pageviews

October's most-viewed medications included:

• Gardasil, Merck & Co.
• Humira, Abbott Laboratories
• Herceptin, Genentech
• Gleevec, Novartis
• Cymbalta, Eli Lilly and Company

"dailyRx's Content-as-a-Service solutions enable hospitals, clinics, and health providers to engage their patients at multiple points of presence with timely information patients can relate to and act upon," Hackett said. "Informed patients play a more active role in managing their health, taking an important step toward improving outcomes and reducing overall healthcare expenses."

About The dailyRx News Network

The dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for efficacy by doctors, pharmacists and therapists. dailyRx, Inc. is owned by Patient Conversation Media, Inc.

About Patient Conversation Media, Inc.

Patient Conversation Media, Inc. (PCMi) is a technology-driven media enterprise focused on the digital evolution within the health industry. PCMi's cloud-based Content-as-a-Service platform powers its DTC websites, distributes patient education solutions, and deploys a suite of appointment management solutions across Internet, Mobile, Social Media, and Telephony user experiences. PCMi's national network of physicians, pharmacists and behavioral health providers serves as the primary distribution channel for its solutions. PCMi's portfolio of owned and operated brands includes www.dailyRx.com, www.RxWiki.com, www.1-800-Oncologist.com and www.1-800-Therapist.com.

SOURCE dailyRx, Inc.

Published Nov. 13, 2012— Reads 245
Copyright © 2012 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.